Neola Medical invites to presentation of the Q2-report 2024 - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Investeringserbjudande: RMD – Banbrytande teknik för en effektivare infrastruktur (annons)

Pressmeddelande

Neola Medical invites to presentation of the Q2-report 2024

MFN Publicerad: 06 Aug 13:50
Neola Medical

Neola Medical AB (publ) invites to presentation of the Q2-report of 2024, Thursday the 15th of August 2024 at 12:30 CET (12.30). The presentation will be held online as a webcast hosted by Finwire. The Q2-report will be published the same morning.

Neola Medical publishes the Q2-report in the morning the 15th of August 2024. We hereby invite investors, analysts, and journalists to a combined report presentation and webcast Thursday the 15th of August 2024 at 12:30 CET (12.30). The report will be presented by CEO Hanna Sjöström and CFO Christian Gyllenberg.

Watch the presentation here: https://www.finwire.tv/webcast/neola-medical/q2-2024/ where you also can type in questions in advance and during the presentation that we will be answering live during the Q&A after the presentation.

For further questions after the presentation, contact CFO Christian Gyllenberg through below contact details.

The report and report presentation will be available at Neola Medical’s website:
https://www.neolamedical.com/investors/rapporter-och-finansiell-kalender/

For further information, contact:
Hanna Sjöström, CEO
e-mail: [email protected]
Christian Gyllenberg, CFO
e-mail: [email protected]

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical invites to presentation of the Q2-report 2024

Bifogade filer

Neola Medical invites to presentation of the Q2-report 2024https://storage.mfn.se/cf750d0b-597b-49f0-9d52-9c7a82841b85/neola-medical-invites-to-presentation-of-the-q2-report-2024.pdf

Nyheter om Neola Medical

Läses av andra just nu

Om aktien Neola Medical

Senaste nytt